Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Uber Falls Premarket; Deere, Novavax Rise

Published 02/19/2021, 07:58 AM
Updated 02/19/2021, 07:59 AM
© Reuters.

© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Friday, February 19th. Please refresh for updates.

  • Uber (NYSE:UBER) stock fell 1.9% after the ride-hailing firm lost a Supreme Court ruling in the U.K., meaning its drivers should be classified as “workers” and entitled to rights like minimum wage, holiday pay and rest breaks. This threatens the company’s business model in its largest European market.

  • Deere (NYSE:DE) stock rose 4.9% after the manufacturer of heavy machinery posted a major beat in its fiscal first quarter net profit, citing “improving conditions” in its farm and construction sectors.

  • Novavax (NASDAQ:NVAX) stock rose 7.9% after the drugmaker struck an agreement with global vaccine alliance Gavi to supply 1.1 billion doses of its Covid-19 vaccine to an international vaccination effort.

  • Royal Caribbean (NYSE:RCL) stock rose 1.3% after the cruise operator said it will be restricted from paying cash dividends and from stock buybacks until the third quarter of 2022, due to changes in its loan agreements. 

  • Roku (NASDAQ:ROKU) stock rose 2% after the video-streaming device maker beat quarterly revenue expectations, thanks to subscribers dropping their cable packages for streaming services.

  • TripAdvisor (NASDAQ:TRIP) stock fell 2% after the travel-booking company posted a wider-than-expected loss in the fourth quarter, although it did see signals of growing travel demand.

  • Dropbox (NASDAQ:DBX) stock fell 3.6% after the file hosting service posted a larger than expected loss in the fourth quarter, hit by a one-time impairment charge related to its real estate assets.

  • IBM (NYSE:IBM) stock rose 0.2% after the Wall Street Journal reported that the tech giant is exploring the sale of its Watson Health unit, looking to streamline its operations and become more competitive in cloud computing.

  • Pfizer (NYSE:PFE) stock rose 0.3% after a study showed the drugmaker’s Covid-19 vaccine, developed along with BioNTech, is up to 85% effective after the first dose.

  • Applied Materials (NASDAQ:AMAT) rose 5.3% after the tech company forecast second-quarter revenue above market expectations, as demand for its semiconductor manufacturing tools picked up during a global shortage of semiconductors.

 

Latest comments

Fell? There is no falling. Even cruise lines up 5% a day... normal market conditions.....
AMAT is looking bright for the future, if they meet their objectives it wont stop going higher
The criminal, pre-market manipulation as flagrant as ever.  Another routine day in the US Ponzi Scheme, greatest financial fraud in history, and biggest investment joke in the world.
Sponsored by the FED and DJ Powell
Sorry if u lost. but it is tired, u keep posting the same ******
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.